• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Super Micro Computer Inc.
    $SMCI
    6/26/2025Sector Weight
    KeyBanc Capital Markets
    Super Micro Computer Inc.
    $SMCI
    5/7/2025$39.00Buy
    Needham
    MicroStrategy Incorporated
    $MSTR
    4/29/2025$480.00Buy
    H.C. Wainwright
    Super Micro Computer Inc.
    $SMCI
    4/25/2025$39.00Neutral
    Citigroup
    Nasdaq Inc.
    $NDAQ
    4/17/2025$91.00Neutral → Buy
    Redburn Atlantic
    Nasdaq Inc.
    $NDAQ
    4/8/2025$74.00Overweight → Equal-Weight
    Morgan Stanley
    Palantir Technologies Inc.
    $PLTR
    4/1/2025$90.00Neutral
    Daiwa Securities
    MicroStrategy Incorporated
    $MSTR
    4/1/2025$220.00Neutral → Sell
    Monness Crespi & Hardt
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woersching Eric H. sold $1,337,545 worth of shares (10,214 units at $130.95), decreasing direct ownership by 81% to 2,348 units (SEC Form 4)

      4 - Palantir Technologies Inc. (0001321655) (Issuer)

      7/3/25 4:23:38 PM ET
      $PLTR
      Computer Software: Prepackaged Software
      Technology
    • Director Moore Alexander D. sold $2,621,113 worth of shares (20,000 units at $131.06), decreasing direct ownership by 2% to 1,312,978 units (SEC Form 4)

      4 - Palantir Technologies Inc. (0001321655) (Issuer)

      7/3/25 4:21:33 PM ET
      $PLTR
      Computer Software: Prepackaged Software
      Technology
    • Officer Taylor Ryan D. sold $4,510,452 worth of shares (33,335 units at $135.31) and exercised 33,335 shares at a strike of $4.72 (SEC Form 4)

      4 - Palantir Technologies Inc. (0001321655) (Issuer)

      7/3/25 4:20:29 PM ET
      $PLTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Patten Jarrod M bought $425,000 worth of Series A Perpetual Stride Preferred Stock (5,000 units at $85.00) (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      6/9/25 7:45:05 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • EVP & General Counsel Shao Wei-Ming converted options into 3,830 shares, bought $299,795 worth of Series A Perpetual Stride Preferred Stock (3,527 units at $85.00) and sold $637,094 worth of shares (1,701 units at $374.54), increasing direct ownership by 20% to 12,726 units (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      6/9/25 7:41:18 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • EVP & CFO Kang Andrew sold $703,012 worth of shares (1,877 units at $374.54), converted options into 4,260 shares and bought $191,250 worth of Series A Perpetual Stride Preferred Stock (2,250 units at $85.00), increasing direct ownership by 11% to 24,460 units (SEC Form 4)

      4 - MICROSTRATEGY Inc (0001050446) (Issuer)

      6/9/25 7:39:53 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    See more
    • SEC Form 8-K filed by MicroStrategy Incorporated

      8-K - MICROSTRATEGY Inc (0001050446) (Filer)

      7/7/25 9:03:59 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • SEC Form FWP filed by MicroStrategy Incorporated

      FWP - MICROSTRATEGY Inc (0001050446) (Subject)

      7/7/25 8:35:59 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B5 filed by MicroStrategy Incorporated

      424B5 - MICROSTRATEGY Inc (0001050446) (Filer)

      7/7/25 8:33:40 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    See more
    • Strategy Announces $4.2 Billion STRD At-The-Market Program

      Strategy™ (NASDAQ:MSTR, STRK, STRF, STRD)) today announced that it has entered into a sales agreement pursuant to which Strategy may issue and sell shares of its 10.00% Series A Perpetual Stride Preferred Stock, $0.001 par value per share (the "STRD Stock"), having an aggregate offering price of up to $4.2 billion (the "ATM Program"). Strategy expects to make sales of STRD Stock pursuant to the ATM Program in a disciplined manner over an extended period, taking into account the trading price and trading volumes of the STRD Stock at the time of sale. Strategy intends to use the net proceeds from the ATM Program for general corporate purposes, including the acquisition of bitcoin and for

      7/7/25 8:30:00 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • Nasdaq to Hold Second Quarter 2025 Investor Conference Call

      NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) has scheduled its second quarter 2025 financial results announcement.  Who:Nasdaq's CEO, CFO, and additional members of its senior management team    What:Review Nasdaq's second quarter 2025 financial results    When:Thursday, July 24, 2025  Results Call: 8:00 AM Eastern    Senior management will be available for questions from the investment community following prepared remarks. All participants can access the conference via webcast through the Nasdaq Investor Relations website at http://ir.nasdaq.com/. Note: The press release and results presentation for the second quarter 2025 results will be posted on the Nasdaq Investo

      6/26/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

      Investment supports platform innovation, commercial scaling, and new service development; Infinity acquires the assets of Serimmune, Inc. Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Series A financing round. The round was led by Illumina Ventures, with participation from PTX Capital, Blackbird BioVentures, and Propel Baltimore Fund. As part of the strategic plan to broaden its suite of service offerings, Infinity Bio has acquired the assets of Serimmune, Inc., which was founded in 2014 to provide unbiased antibody reactome services. New MIPSA™ service offerings, including EnviroSI

      6/18/25 9:00:00 AM ET
      $ILMN
      Medical Specialities
      Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    See more
    • Nasdaq Welcomes 142 IPOs in the First Half of 2025

      Highest volume of listings and capital raise in the first half of the year since 2021 Maintained leadership in switches - crossed $3 trillion in market value transferred since 2005 Driving smart policy reforms to improve regulatory processes for public companies NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in the first half of 2025, it welcomed 142 listings (IPOs), raising a total of $19.2 billion. A total of 83 operating companies and 59 SPACs listed on Nasdaq during the first six months of 2025, representing an 86% win-rate of Nasdaq-eligible listings in the U.S. market, and extending Nasdaq's leadership to 46 consecutive quarters. In add

      7/1/25 8:05:00 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • New AI Rollouts Signal Shift From Hype to Healthcare Reality

      USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

      6/24/25 9:45:00 AM ET
      $LLY
      $PHG
      $PLTR
      $WAY
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical Electronics
      Computer Software: Prepackaged Software
    • Nasdaq Announces Results from 2025 Annual Meeting of Shareholders

      All 12 Nominated Directors Elected Nasdaq Board Re-elects Adena T. Friedman as Chair of the Board NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) shareholders elected all nominated directors at the company's Annual Meeting of Shareholders on Wednesday, June 11, 2025. All directors will serve one-year terms. The elected board members are: Melissa M. Arnoldi, EVP and General Manager for Business Solutions, AT&T Inc.Charlene T. Begley, Retired SVP and CIO, General Electric CompanyAdena T. Friedman, Chair and CEO, NasdaqEssa Kazim, Governor, Dubai International Financial CentreThomas A. Kloet, Retired CEO and Executive Director, TMX Group LimitedKathryn A. Koch, Presi

      6/16/25 4:30:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

      For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

      11/30/20 5:12:14 PM ET
      $MRNA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on Super Micro Computer

      KeyBanc Capital Markets initiated coverage of Super Micro Computer with a rating of Sector Weight

      6/26/25 8:11:57 AM ET
      $SMCI
      Computer Manufacturing
      Technology
    • Needham resumed coverage on Super Micro Computer with a new price target

      Needham resumed coverage of Super Micro Computer with a rating of Buy and set a new price target of $39.00

      5/7/25 8:38:19 AM ET
      $SMCI
      Computer Manufacturing
      Technology
    • H.C. Wainwright initiated coverage on MicroStrategy d/b/a Strategy with a new price target

      H.C. Wainwright initiated coverage of MicroStrategy d/b/a Strategy with a rating of Buy and set a new price target of $480.00

      4/29/25 8:12:45 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Strategy Announces $4.2 Billion STRD At-The-Market Program

      Strategy™ (NASDAQ:MSTR, STRK, STRF, STRD)) today announced that it has entered into a sales agreement pursuant to which Strategy may issue and sell shares of its 10.00% Series A Perpetual Stride Preferred Stock, $0.001 par value per share (the "STRD Stock"), having an aggregate offering price of up to $4.2 billion (the "ATM Program"). Strategy expects to make sales of STRD Stock pursuant to the ATM Program in a disciplined manner over an extended period, taking into account the trading price and trading volumes of the STRD Stock at the time of sale. Strategy intends to use the net proceeds from the ATM Program for general corporate purposes, including the acquisition of bitcoin and for

      7/7/25 8:30:00 AM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology
    • iRhythm Technologies Announces Board Member Retirements and New Director Appointments

      SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O'Boyle have accepted appointments to the board of directors. Mark Rubash has served on the board since 2016, prior to the company's initial public offering, bringing decades of experience in finance, accounting, and strategy at high-growth technology companies. Ralph Snyderman, M.D., who joined the board in 2017, br

      7/7/25 8:30:00 AM ET
      $ABSI
      $ATEC
      $ILMN
      $IRTC
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Medical/Dental Instruments
      Medical Specialities
    • JLens and ADL Condemn UN Report Targeting Companies for Israel Ties

      TOV ETF Currently Holds All 13 of the U.S. Public Companies Named in Report and Reaffirms Support for Israel-Aligned Investments JLens, a Registered Investment Advisor and sponsor of the JLens 500 Jewish Advocacy U.S. ETF (NYSE:TOV, the "TOV ETF")), along with the Anti-Defamation League (ADL), the world's leading anti-hate organization, strongly condemn the report issued by UN Special Rapporteur Francesca Albanese during the 59th session of the UN Human Rights Council. Titled "From economy of occupation to economy of genocide," the report urges companies to sever ties with Israel, halt operations, and pay reparations. This press release features multimedia. View the full release here: ht

      7/3/25 11:45:00 AM ET
      $ABNB
      $AMZN
      $BKNG
      $BLK
      Diversified Commercial Services
      Finance
      Catalog/Specialty Distribution
      Consumer Discretionary

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Illumina Inc.

      SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

      12/6/24 10:11:24 AM ET
      $ILMN
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Illumina Inc.

      SC 13G - ILLUMINA, INC. (0001110803) (Subject)

      12/5/24 7:27:01 PM ET
      $ILMN
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by MicroStrategy Incorporated

      SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

      11/14/24 6:24:12 PM ET
      $MSTR
      Computer Software: Prepackaged Software
      Technology